sb 239063 has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joshi, SD; Karunakaran, S; Meka, DP; Mishra, M; Ravindranath, V; Saeed, U; Seth, P; Valli, RK | 1 |
| Karunakaran, S; Ravindranath, V | 1 |
2 other study(ies) available for sb 239063 and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Benzothiazoles; Brain; Cells, Cultured; Disease Models, Animal; Dopamine; Enzyme Activation; Enzyme Inhibitors; Fetus; Humans; Imidazoles; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurons; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; Protein Transport; Pyrimidines; Stem Cells; Substantia Nigra; Time Factors; Toluene; Tumor Suppressor Protein p53; Tyrosine 3-Monooxygenase; Up-Regulation | 2008 |
Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-kappaB in MPTP-treated mice: implication in Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; bcl-Associated Death Protein; Cell Nucleus; Dopamine Agents; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Imidazoles; Male; Mice; Mice, Inbred C57BL; Neurons; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Protein Transport; Pyrimidines; Serine; Substantia Nigra; Time Factors | 2009 |